Mildly symptomatic chronic mitral regurgitation. Analysis of left ventricular systolic function and mitral regurgitation fraction under pharmacological influence. Echocardiographic study. 2003

Ivan Romero Rivera, and Valdir Ambrósio Moisés, and Antonio Carlos Carvalho, and Angelo Amato V de Paola
Escola Paulista de Medicina, UNIFESP, São Paulo, SP, Brazil. irrivera@uol.com.br

OBJECTIVE To study echocardiographic parameters of left ventricular systolic function and valvar regurgitation under pharmacological influence in mildly symptomatic patients with chronic mitral regurgitation (MR). METHODS We carried out a double-blind placebo controlled study in 12 patients with MR, mean aged 12.5 years old, who were randomized in 4 phases: A) digoxin; B) enalapril; C) digoxin + enalapril; D) placebo. The medication was administered for 30 days in each phase, and the following variables were analyzed: shortening and ejection fractions, wall stress index of left ventricle, left ventricular meridional end-systolic wall stress, Doppler-derived mean rate of left ventricular pressure rise (mean dP/dt), stroke volume and MR jet area. The clinical variables analysed were heart rate and systemic arterial pressure. RESULTS No significant variation was observed in the clinical variables analysed. The shortening and ejection fraction, the mean dP/dt and stroke volume significantly increased and the wall stress index of left ventricle, the meridional left ventricular end systolic wall stress and the mitral regurgitation jet area decreased in the phases with medication as compared with that in the placebo phase. CONCLUSIONS The parameters of left ventricular systolic function improved significantly and the degree of MR decreased with the isolated administration of digoxin or enalapril in mildly symptomatic patients with chronic MR. The combination of the drugs, however, did not show better results.

UI MeSH Term Description Entries
D008297 Male Males
D008944 Mitral Valve Insufficiency Backflow of blood from the LEFT VENTRICLE into the LEFT ATRIUM due to imperfect closure of the MITRAL VALVE. This can lead to mitral valve regurgitation. Mitral Incompetence,Mitral Regurgitation,Mitral Valve Incompetence,Mitral Insufficiency,Mitral Valve Regurgitation,Incompetence, Mitral,Incompetence, Mitral Valve,Insufficiency, Mitral,Insufficiency, Mitral Valve,Regurgitation, Mitral,Regurgitation, Mitral Valve,Valve Incompetence, Mitral,Valve Insufficiency, Mitral,Valve Regurgitation, Mitral
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D004077 Digoxin A cardiotonic glycoside obtained mainly from Digitalis lanata; it consists of three sugars and the aglycone DIGOXIGENIN. Digoxin has positive inotropic and negative chronotropic activity. It is used to control ventricular rate in ATRIAL FIBRILLATION and in the management of congestive heart failure with atrial fibrillation. Its use in congestive heart failure and sinus rhythm is less certain. The margin between toxic and therapeutic doses is small. (From Martindale, The Extra Pharmacopoeia, 30th ed, p666) Digacin,Digitek,Digoregen,Digoxina Boehringer,Digoxine Nativelle,Dilanacin,Hemigoxine Nativelle,Lanacordin,Lanicor,Lanoxicaps,Lanoxin,Lanoxin-PG,Lenoxin,Mapluxin,Boehringer, Digoxina,Lanoxin PG,Nativelle, Digoxine,Nativelle, Hemigoxine
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004656 Enalapril An angiotensin-converting enzyme inhibitor that is used to treat HYPERTENSION and HEART FAILURE. Enalapril Maleate,MK-421,MK421,Renitec,Renitek,MK 421,Maleate, Enalapril
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

Ivan Romero Rivera, and Valdir Ambrósio Moisés, and Antonio Carlos Carvalho, and Angelo Amato V de Paola
October 2013, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography,
Ivan Romero Rivera, and Valdir Ambrósio Moisés, and Antonio Carlos Carvalho, and Angelo Amato V de Paola
March 2016, European heart journal,
Ivan Romero Rivera, and Valdir Ambrósio Moisés, and Antonio Carlos Carvalho, and Angelo Amato V de Paola
August 1989, Journal of the American College of Cardiology,
Ivan Romero Rivera, and Valdir Ambrósio Moisés, and Antonio Carlos Carvalho, and Angelo Amato V de Paola
December 1997, Circulation,
Ivan Romero Rivera, and Valdir Ambrósio Moisés, and Antonio Carlos Carvalho, and Angelo Amato V de Paola
January 2020, Journal of clinical ultrasound : JCU,
Ivan Romero Rivera, and Valdir Ambrósio Moisés, and Antonio Carlos Carvalho, and Angelo Amato V de Paola
January 2010, The Journal of heart valve disease,
Ivan Romero Rivera, and Valdir Ambrósio Moisés, and Antonio Carlos Carvalho, and Angelo Amato V de Paola
November 1992, Circulation,
Ivan Romero Rivera, and Valdir Ambrósio Moisés, and Antonio Carlos Carvalho, and Angelo Amato V de Paola
February 1984, Journal of the American College of Cardiology,
Ivan Romero Rivera, and Valdir Ambrósio Moisés, and Antonio Carlos Carvalho, and Angelo Amato V de Paola
January 2016, Heart failure reviews,
Ivan Romero Rivera, and Valdir Ambrósio Moisés, and Antonio Carlos Carvalho, and Angelo Amato V de Paola
December 2014, The Journal of thoracic and cardiovascular surgery,
Copied contents to your clipboard!